23andMe Raises $9 Million From MPM Capital and Johnson & Johnson

Posted Jan 12, 2011

Genetics company 23andMe has raised $9 million to add to the $22 million Series C round that they announced this past November. MPM Capital and Johnson & Johnson Development Corporation participated in the $9 million financing. MPM Capital Managing Director Ashley Ledbetter will be joining 23andMe’s board of directors. 23andMe now has a total of $54 million in funding. [TechCrunch]